We harness
our technology,

employing synthetic genomics and non-canonical amino acids to craft advanced biopolymers.

Technology

Next Generation Biologics

We expand the chemical toolkit of cells to produce innovative biologics with site-specific functionalisation for improved precision, potency, and patient outcomes. Our technology functionalises molecules with unprecedented specificity and fidelity

Technology

Programmable Biomolecules

We hijack the protein translation machinery of cells to produce sequence-defined biopolymers at scale. Customisable biomolecules, meticulously crafted with non-canonical building blocks, unlocking new dimensions in therapeutics, chemicals, biomaterials, and beyond

Technology

Syn61 Bioproduction

With supply chains increasingly reliant on bioproduction, the resilience and robustness of bioprocesses is critical. Syn61, our flagship strain, has built in firewalls against phage attack and horizontal gene transfer. Syn61 is the first of a new class of synthetic organisms designed for reliable and safe biomanufacturing

Our Science

Embark on a Scientific Odyssey to Uncover the
Innovation Behind Our Science

Delve into the insights of Our Science page!

Our cutting edge technologies unlock a vast array of applications, presenting boundless possibilities for the future.

Freddie Dudbridge

Freddie Dudbridge

Commercial and Development Manager at Constructive.Bio

Our cutting edge technologies unlock a vast array of applications, presenting boundless possibilities for the future.

Freddie Dudbridge

Freddie Dudbridge

Commercial and Development Manager at Constructive.Bio

Our cutting edge technologies unlock a vast array of applications, presenting boundless possibilities for the future.

Freddie Dudbridge

Freddie Dudbridge

Commercial and Development Manager at Constructive.Bio

Our Case Studies

Peptides with non-canonical amino acids

The making of Syn61